Ritonavir News and Research

RSS
Ritonavir, also known as Norvir, is a type of medicine called a protease inhibitor (PI). PIs act by blocking protease, a protein that HIV needs to make more copies of itself. Ritonavir was approved by the FDA on March 1, 1996, for use with other antiretroviral agents in the treatment of HIV infection in adults and children 2 years of age or older. Ritonavir is now approved with other anti-HIV drugs in the treatment of HIV-1 infection in children in individuals over 1 month in age. Studies have shown that ritonavir works as a booster for some other PIs. Taking ritonavir makes it possible to take a lower dose of the other PIs. This medicine does not cure or prevent HIV infection or AIDS and does not reduce the risk of passing the virus to other people.
Is the confidence in hydroxychloroquine for the management of COVID-19 justified?

Is the confidence in hydroxychloroquine for the management of COVID-19 justified?

New clinical trial to test two drugs for prophylactic treatment of COVID-19 contact persons

New clinical trial to test two drugs for prophylactic treatment of COVID-19 contact persons

HIV-1 and influenza antivirals not effective for treating mild-to-moderate COVID-19 cases

HIV-1 and influenza antivirals not effective for treating mild-to-moderate COVID-19 cases

Research suggests Nelfinavir and Cepharanthine as potential anti-SARS-CoV-2 agents

Research suggests Nelfinavir and Cepharanthine as potential anti-SARS-CoV-2 agents

China with the world: COVID-19 experts dialogues - the 4th talk transcript

China with the world: COVID-19 experts dialogues - the 4th talk transcript

Cost of ‘repurposing’ existing drugs to treat COVID-19

Cost of ‘repurposing’ existing drugs to treat COVID-19

Remdesivir shows promise in post-infection treatment for COVID-19 disease

Remdesivir shows promise in post-infection treatment for COVID-19 disease

Will 'old faithful' tuberculosis BCG vaccine work against COVID?

Will 'old faithful' tuberculosis BCG vaccine work against COVID?

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

Critical guidance to identify COVID-19 patients at risk of drug-induced sudden cardiac death

Projects to develop COVID-19 vaccines receive U.K. gov’t funding

Projects to develop COVID-19 vaccines receive U.K. gov’t funding

Huge WHO trial of COVID-19 therapies begins

Huge WHO trial of COVID-19 therapies begins

First patients enrolled in new clinical trial to evaluate potential COVID-19 treatments

First patients enrolled in new clinical trial to evaluate potential COVID-19 treatments

Lopinavir and ritonavir drug combo tested in severe COVID-19

Lopinavir and ritonavir drug combo tested in severe COVID-19

The changing face of the COVID-19 epidemic

The changing face of the COVID-19 epidemic

To fight Chinese outbreak, doctors deploy drugs targeting HIV, malaria and Ebola

To fight Chinese outbreak, doctors deploy drugs targeting HIV, malaria and Ebola

New drug delivery system could be a boon for those on a multi-drug regimen

New drug delivery system could be a boon for those on a multi-drug regimen

Getting right level of leptin may help protect cardiovascular health

Getting right level of leptin may help protect cardiovascular health

FDA approves first vaginal ring contraceptive that can be used for one year

FDA approves first vaginal ring contraceptive that can be used for one year

New HIV prevention guidelines from Canada released

New HIV prevention guidelines from Canada released

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients

U.S. FDA approves updated labeling for pan-genotypic single tablet regimen for HCV/HIV co-infected patients